Dishman Carbogen Amcis Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹149.5
- Today's High:
- ₹160.85
- Open Price:
- ₹160.15
- 52W Low:
- ₹80.05
- 52W High:
- ₹171.05
- Prev. Close:
- ₹158.55
- Volume:
- 978167
Company Statistics
- Market Cap.:
- ₹24.93 billion
- Book Value:
- 370.498
- Revenue TTM:
- ₹25.96 billion
- Operating Margin TTM:
- 3.46%
- Gross Profit TTM:
- ₹15.73 billion
- Profit Margin:
- -0.65%
- Return on Assets TTM:
- 0.36%
- Return on Equity TTM:
- -0.53%
Company Profile
Dishman Carbogen Amcis Limited had its IPO on under the ticker symbol DCAL.
The company operates in the Healthcare sector and Biotechnology industry. Dishman Carbogen Amcis Limited has a staff strength of 1,295 employees.
Stock update
Shares of Dishman Carbogen Amcis Limited opened at ₹160.15 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹149.5 - ₹160.85, and closed at ₹152.1.
This is a -4.07% slip from the previous day's closing price.
A total volume of 978,167 shares were traded at the close of the day’s session.
In the last one week, shares of Dishman Carbogen Amcis Limited have slipped by -3.49%.
Dishman Carbogen Amcis Limited's Key Ratios
Dishman Carbogen Amcis Limited has a market cap of ₹24.93 billion, indicating a price to book ratio of 0.2717 and a price to sales ratio of 0.6571.
In the last 12-months Dishman Carbogen Amcis Limited’s revenue was ₹25.96 billion with a gross profit of ₹15.73 billion and an EBITDA of ₹3.98 billion. The EBITDA ratio measures Dishman Carbogen Amcis Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Dishman Carbogen Amcis Limited’s operating margin was 3.46% while its return on assets stood at 0.36% with a return of equity of -0.53%.
In Q2, Dishman Carbogen Amcis Limited’s quarterly earnings growth was a positive 315.4% while revenue growth was a positive 33.8%.
Dishman Carbogen Amcis Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹-1.07 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Dishman Carbogen Amcis Limited’s profitability.
Dishman Carbogen Amcis Limited stock is trading at a EV to sales ratio of 1.3623 and a EV to EBITDA ratio of 10.156. Its price to sales ratio in the trailing 12-months stood at 0.6571.
Dishman Carbogen Amcis Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹94.54 billion
- Total Liabilities
- ₹17.98 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Dishman Carbogen Amcis Limited ended 2024 with ₹94.54 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹94.54 billion while shareholder equity stood at ₹58.10 billion.
Dishman Carbogen Amcis Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹17.98 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹38.64 billion in goodwill. Its cash balance stood at ₹1.32 billion and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹10.47 billion.
Dishman Carbogen Amcis Limited’s total current assets stands at ₹19.18 billion while long-term investments were ₹0 and short-term investments were ₹2.41 billion. Its net receivables were ₹5.90 billion compared to accounts payable of ₹2.20 billion and inventory worth ₹8.04 billion.
In 2024, Dishman Carbogen Amcis Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Dishman Carbogen Amcis Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹152.1
- 52-Week High
- ₹171.05
- 52-Week Low
- ₹80.05
- Analyst Target Price
- ₹
Dishman Carbogen Amcis Limited stock is currently trading at ₹152.1 per share. It touched a 52-week high of ₹171.05 and a 52-week low of ₹171.05. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹153.22 and 200-day moving average was ₹123.49 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7001.6% of the company’s stock are held by insiders while 419.4% are held by institutions.
Frequently Asked Questions About Dishman Carbogen Amcis Limited
Similar Industry Stocks (Biotechnology)
Most Active
Top Gainers
Top Losers
About
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry in India and internationally. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitizers, antiseptics, vitamin D analogues, cholesterol, lanolin-related products, disinfectant formulations, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited operates as a subsidiary of Adimans Technologies LLP.